MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

HAE — Haemonetics Corporation

NYSE

Haemonetics Corporation

CompareBack to Screener
$104.68
+0.31(+0.30%)
O
104.58
H
105.70
L
103.61
V
328.51K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About HAE

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateMay 9, 1991
Employees3,009
Stock ExchangeNYSE
Ticker SymbolHAE

Key Financial Statistics

Market Cap$4.76B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$48.17 - $110.45
52-Week Avg Volume822.6K
VWAP$104.80
Transactions9,185
Total Recorded Bars8,912 days